Skyward Specialty Insurance Group (SKWD) Chairman to Resign

Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) announced a series of changes to its Board of Directors (the “Board”) effective Thursday, November 30, 2023.

Cameron MacDonald, president and chief executive officer at The Westaim Corporation and current Chairperson of the Board, and Robert Kittel, chief operating officer at Westaim and current Board member, have resigned their positions on the Skyward Specialty Board of Directors. Both Mr. MacDonald and Mr. Kittel have served on the Board for nearly 10 years. With the successful completion of the Company’s recent offering, in which Westaim sold a significant portion of their holdings in the Company, Mr. MacDonald and Mr. Kittel concluded it was an appropriate time to leave the Board.

“I want to thank Cam and Rob for their stewardship, service, and longstanding commitment to the Company. Their leadership and support for our vision and strategy was instrumental in our journey to becoming the leading specialty carrier we are today,” Andrew Robinson, chief executive officer at Skyward Specialty commented.

With Mr. MacDonald’s departure, Mr. Robinson will assume the position of Chairperson of the Board. Additionally, Tony Kuczinski has been named Lead Independent Director.

Mr. Kuczinski stated, “The Board believes that Andrew is unquestionably the right person to assume the chair for the Company at this point in its development. We have the utmost confidence in his ability to lead the Board through this next phase of Company development.”

Mr. Robinson further commented, “I feel privileged to take on the role as Chair of the Board at such an exciting time for our Company. I am also excited to have Tony serve as our Lead Independent Director. His experience, perspective, wisdom and distinct standing in the Property & Casualty market will serve our Company incredibly well as we look to the future.”

You May Also Be Interested In

• NovaRed Mining adds Katie Zacharia to its advisory board
• Ian Wendler to retire from Jewett-Cameron board by July 31
• Avalo Therapeutics adds Ron Philip to its board of directors